Related Experiment Video
Updated: Jan 26, 2026

Oncogene Expression Analysis with Alterations in pH in a Pancreatic Ductal Cell Line
Published on: April 11, 2025
JAK3/STAT3 oncogenic pathway and PRDM1 expression stratify clinicopathologic features of extranodal NK/T‑cell
Jumei Liu1, Li Liang1, Dong Li1
1Department of Pathology, Peking University First Hospital, Beijing 100034, P.R. China.
Abstract:
The inactivation of tumor suppressor gene positive regulatory domain containing I (PRDM1) and activation of signal transducer and activator of transcription 3 (STAT3) have been detected in the majority of extranodal NK/T‑cell lymphoma, nasal type (EN‑NK/T‑NT) cases. In the present study, their association with and effects on the clinicopathologic features of EN‑NK/T‑NT are described. PRDM1 was revealed to be expressed in 19 out of 58 patients (32.8%) with EN‑NK/T‑NT, and phosphorylated STAT3 was overexpressed in 42 out of 58 (72.4%). Oncogenic pathways were investigated by NanoString encounter technology in 5 PRDM1(+) and 5 PRDM1(‑) EN‑NK/T‑NT specimens. Multiple oncogenic pathways involved in cell apoptosis, cellcycle (CC) and angiogenesis were discriminately activated in EN‑NK/T‑NT cases, and in PRDM1(+) cases in particular. The sustained activation of the Janus kinase 3 (JAK)/STAT3 pathway was more pronounced. In addition, missense mutations in the SRC homology 2 domain of STAT3 were detected in 7 out of 37 EN‑NK/T‑NT cases (18.92%), and the acquired mutation was related to the activation of the JAK3/STAT3 pathway. The downregulation of PRDM1 and upregulation of phospho‑STAT3 (Tyr705) were associated with angiocentric infiltration of EN‑NK/T‑NT (P=0.039). Notably, the prognosis of patients in the PRDM1(+)/STAT3 [mutated (mut‑)] group was considerably improved than that of patients in the STAT3(mut+)/PRDM(‑) group (P=0.037). In addition, the inhibition of NK/T cell lymphoma cell lines by Stattic and tofacitinib could suppress cell proliferation by inducing cell apoptosis or arresting the CC. The present results revealed that the JAK3/STAT3 oncogenic pathway and PRDM1 expression could stratify clinicopathologic features of EN‑NK/T‑NT. The inhibition of the JAK3/STAT3 pathway may serve as a treatment option for EN‑NK/T‑NT.
Insights
In extranodal NK/T-cell lymphoma, nasal type (EN‑NK/T‑NT), PRDM1 inactivation and STAT3 activation are common. Targeting the JAK3/STAT3 pathway may offer a new treatment strategy for EN‑NK/T‑NT.
Area of Science:
- Oncology
- Molecular Biology
- Immunology
Background:
- Extranodal NK/T-cell lymphoma, nasal type (EN‑NK/T‑NT) frequently exhibits PRDM1 gene inactivation and STAT3 pathway activation.
- These molecular alterations are implicated in the pathogenesis and progression of EN‑NK/T‑NT.
Purpose of the Study:
- To investigate the association between PRDM1 expression, STAT3 activation, and clinicopathologic features in EN‑NK/T‑NT.
- To explore the role of oncogenic pathways, including JAK3/STAT3, in EN‑NK/T‑NT.
- To evaluate the therapeutic potential of targeting the JAK3/STAT3 pathway.
Main Methods:
- Analysis of PRDM1 expression and phosphorylated STAT3 (p-STAT3) in EN‑NK/T‑NT patient samples.
- NanoString nCounter technology to investigate oncogenic pathways in PRDM1-positive and PRDM1-negative specimens.
- Detection of STAT3 mutations using sequencing.
- In vitro studies using Stattic and tofacitinib to inhibit JAK3/STAT3 signaling in lymphoma cell lines.
Main Results:
- PRDM1 was expressed in 32.8% and p-STAT3 overexpressed in 72.4% of EN‑NK/T‑NT cases.
- Multiple oncogenic pathways, particularly JAK3/STAT3, were activated in EN‑NK/T‑NT, with pronounced activation in PRDM1-positive cases.
- STAT3 mutations were found in 18.92% of cases and correlated with JAK3/STAT3 pathway activation.
- Downregulation of PRDM1 and upregulation of p-STAT3 were associated with angiocentric infiltration (P=0.039).
- Patients with PRDM1 positivity and wild-type STAT3 had a better prognosis than those with PRDM1 negativity and mutated STAT3 (P=0.037).
- Inhibition of JAK3/STAT3 signaling suppressed lymphoma cell proliferation by inducing apoptosis and cell cycle arrest.
Conclusions:
- PRDM1 expression and JAK3/STAT3 pathway activation are significant factors that can stratify clinicopathologic features and prognosis in EN‑NK/T‑NT.
- Targeting the JAK3/STAT3 pathway represents a promising therapeutic strategy for EN‑NK/T‑NT.
Related Concept Videos
Stratified Sampling Method
To choose a stratified sample, divide the population into groups called strata and then take a...
Immune Surveillance by NK Cells and Phagocytes
Natural Killer Cells: The Fast Responders
NK cells are large granular lymphocytes found in the blood and lymphatic system. These...
Cell Specific Gene Expression
C4 Pathway and CAM
C4 Pathway
The C4 pathway is used by plants such as...
Classification of Epithelial Tissues: Stratified Epithelium
Nose and Nasal Cavity

